Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients
Gottlieb AB, Mease PJ, Kirkham B, Nash P, Balsa A, Combe B, Rech J, Martin R, Ligozio G, Abrams K, Pricop L (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 70
Authors with CRIS profile
Involved external institutions
Novartis AG
Switzerland (CH)
University of Montpellier / Université Montpellier
France (FR)
Guy's and St Thomas' (NHS Foundation Trust)
United Kingdom (GB)
Swedish Medical Center
United States (USA) (US)
Hospital Universitario La Paz
Spain (ES)
NYC Health + Hospitals
United States (USA) (US)
University of Queensland
Australia (AU)
Switzerland (CH)
University of Montpellier / Université Montpellier
France (FR)
Guy's and St Thomas' (NHS Foundation Trust)
United Kingdom (GB)
Swedish Medical Center
United States (USA) (US)
Hospital Universitario La Paz
Spain (ES)
NYC Health + Hospitals
United States (USA) (US)
University of Queensland
Australia (AU)
How to cite
APA:
Gottlieb, A.B., Mease, P.J., Kirkham, B., Nash, P., Balsa, A., Combe, B.,... Pricop, L. (2018). Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients.
MLA:
Gottlieb, Alice B., et al. "Secukinumab Efficacy in Psoriatic Arthritis: Individual Patient Meta-Analysis of Four Phase 3 Trials in 2049 Patients." 2018.
BibTeX: Download